Hydroxychloroquine reduces IL-6 and pro-thrombotic status

Autoimmun Rev. 2020 Jul;19(7):102555. doi: 10.1016/j.autrev.2020.102555. Epub 2020 May 12.

¹ Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, and SCDU Nephrology and Dialysis, S. Giovanni Bosco Hospital and University of Turin, Italy. Electronic address: savino.sciascia@unito.it.
² Thrombosis and Haemostasis, Guy's and St Thomas' NHS Foundation Trust, London; Copenhagen Lupus and Vasculitis Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Danish Institute of Regional Health Research, University of Southern Denmark, Denmark. Electronic address: Karen.Schreiber@gstt.nhs.uk.
³ Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, and SCDU Nephrology and Dialysis, S. Giovanni Bosco Hospital and University of Turin, Italy.
⁴ Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

No abstract available

Publication types